| Pharmaceutical active ingredients: |
| Nimodipine |
| Available forms, composition and doses of Vasotop: |
| Injectable; Infusion; Nimodipine 0.6 mg / mlTablets; Oral; Nimodipine 30 mg |
| Vasotop medical category: |
| Human:Nootropics and neurotonicsPeripheral vasodilators and cerebral activatorsVasodilatating agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C08CA06 - Nimodipine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Cipla |